Thursday, May 21, 2020

HYDROXYCHLOROQUINE
Hydroxychloroquine has two characteristics that preclude its official sanction for use against the COVID virus.  First, it’s in ample supply.  It has been around for over fifty years as a treatment for lupus and malaria. Thousands of people have taken it with little or no side effects.  Thus it’s in amply supply.  Second, it’s cheap. It costs pennies per pill.  There are no big $bucks to be made from its use. Thus, the big pharmaceutical companies and their allies in the scientific community rail against it in spite of numerous instances where it has been successfully used to treat the COVID virus.
It has nothing to do with medical necessity.  It’s all about power that translates into money. 

0 Comments:

Post a Comment

<< Home